(Q37728731)

22 August 2017

1 reference

title

Drug-resistant tuberculosis in the European Union: opportunities and challenges for control (English)

1 reference

22 August 2017

0 references

Alimuddin Zumla

4

0 references

Stefan Kaufmann

object named as

Stefan Kaufmann

2

0 references

author name string

Robin Fears

1

1 reference

22 August 2017

Volker Ter Meulen

3

1 reference

22 August 2017

EASAC Working Group

5

1 reference

22 August 2017

publication date

10 April 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

90

1 reference

22 August 2017

issue

3

1 reference

22 August 2017

page(s)

182-187

1 reference

Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.03.008

Epidemiology and clinical management of XDR-TB: a systematic review by TBNET.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.03.008

125 years after Robert Koch's discovery of the tubercle bacillus: the new XDR-TB threat. Is "science" enough to tackle the epidemic?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.03.008

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.03.008

Stopping TB in Europe: some progress but still not there

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.03.008

Drug resistant tuberculosis: Service for drug resistant tuberculosis exists in the UK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.03.008

Changing funding patterns in tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.03.008

Tuberculosis--the tide can be turned, the battle can be won

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.03.008

7 January 2021

Research and recovery

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.03.008

Europe's research system must change

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.03.008

The added value of a European Union tuberculosis reference laboratory network--analysis of the national reference laboratory activities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.03.008

Public health. A National Tuberculosis Archive

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.03.008

Tuberculosis: Deadly combination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.03.008

Modeling the impact of tuberculosis control strategies in highly endemic overcrowded prisons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.03.008

European Commission is not paying its share towards TB research, charity says

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.03.008

7 January 2021

New Year's resolutions

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.03.008

Multidrug-resistant and extensively drug-resistant tuberculosis: the National Institute of Allergy and Infectious Diseases Research agenda and recommendations for priority research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.03.008

The scent of Mycobacterium tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.03.008

Tuberculosis vaccine development: goals, immunological design, and evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.03.008

Medicine. A portfolio model of drug development for tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2010.03.008

10.1016/J.TUBE.2010.03.008

7 January 2021

Identifiers

DOI

1 reference

22 August 2017

1 reference